Jeff Craven

Digital Medicines: A Solution to Medication Nonadherence?

04/19/2019

Could medication with built-in digital sensors improve medication adherence and reduce health care costs? Experts discuss the potential benefits of novel digital medicines against privacy concerns of large-scale data collection.

Could medication with built-in...

04/19/2019

First Report Managed Care

Cover Story

Can Cost-Plus Pricing Lower the Cost of Generic Drugs for Patients?

04/18/2022

Jeff Craven ;

With the ever-rising costs of medications, new business models and patient care initiatives are becoming increasingly common methods to disrupt the industry to instill lasting change. But how do these recent ventures, like Mark Cuban’s new...

With the ever-rising costs of...

04/18/2022

First Report Managed Care

Big Pharma Embraces Big Data: What This Means for Payers and Patients

11/16/2018

Jeff Craven ;

Pharmaceutical companies are increasingly using big data techniques to improve outcomes, streamline the drug clinical pipeline and gain insight into new therapies. But real innovation may change how drug developers, payers, and providers...

Pharmaceutical companies are...

11/16/2018

First Report Managed Care

A Novel—And Cost-Effective—Approach to End-Stage Renal Disease

09/18/2018

Jeff Craven ;

Studies have shown success with hepatitis C-positive kidney transplantation in patients with end-stage renal disease followed by treatment with direct-acting antivirals to cure the infection. Experts discuss why this approach is not only...

Studies have shown success with...

09/18/2018

First Report Managed Care

Innovating Payment Models For Gene Therapy

08/30/2018

Jeff Craven ;

Gene therapy is a transformational treatment for some patients to potentially cure or prevent rare diseases. But questions still remain about how these drugs should be priced and who will pay for them.

Gene therapy is a...

08/30/2018

First Report Managed Care

Formulary Frontlines®

New Options Available for Treatment-Resistant Depression

11/20/2020

Jeff Craven ;

Over the past 30 years, few new pharmacologic therapies have been developed for mood disorders, including depression. However, for patients who do not respond to conventional pharmacologic treatments for MDD, new answers for...

Over the past 30 years, few new...

11/20/2020

First Report Managed Care

Breakthroughs Needed to Combat Antibiotic Resistance

07/23/2019

Jeff Craven ;

Pharmaceutical developments are not keeping pace with mutations in antibiotics; and, while international stakeholders recognize the severity of antimicrobial resistance, new breakthroughs in technology are needed to combat this threat.

Pharmaceutical developments are...

07/23/2019

First Report Managed Care

Drug Shortages Continue: The Effect on Care for Patients in Managed Care Settings

01/28/2019

Jeff Craven ;

Drug shortages have been more prevalent in recent years. Now, the US Food and Drug Administration (FDA), pharmaceutical companies, and other stakeholders are beginning to work together to open conversations about the issue’s causes and...

Drug shortages have been more...

01/28/2019

First Report Managed Care

Concierge Medicine as an Alternative to the Health Care Status Quo

10/13/2018

Jeff Craven ;

Experts say concierge medicine reduces physician burnout and is better for patients. However, ethical and legal questions about transitioning a practice to a concierge model remain.

Experts say concierge medicine...

10/13/2018

First Report Managed Care

Formulary Frontlines®

CGRP Inhibitors May Offer Significant Benefits for Migraine Patients

10/17/2019

Jeff Craven ;

With the advent of calcitonin gene-related peptide (CGRP) inhibitors, which are either monoclonal antibodies or CGRP receptor agonists that block CGRP proteins in the head and neck, another treatment option has emerged for patients where...

With the advent of calcitonin...

10/17/2019

First Report Managed Care